1-10 of 10
Xiaokui Mo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia

Shanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, Lindsey Rike, Xiaokui Mo, Mohamed Badawi, Darlene M. Bystry, Mitch A. Phelps, Leslie A. Andritsos, Kerry A. Rogers, Jeffrey Jones, Jennifer A. Woyach, John C. Byrd, Farrukh T. Awan
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (23): 6187–6195.
https://doi.org/10.1158/1078-0432.CCR-20-1280
Published: 01 December 2020
View article titled, Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia
Open the PDF for Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic Leukemia in another window
Includes: Supplementary data
Journal Articles

A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma

Elizabeth L. McMichael, Brooke Benner, Lakhvir S. Atwal, Nicholas B. Courtney, Xiaokui Mo, Melanie E. Davis, Amanda R. Campbell, Megan C. Duggan, Kallan Williams, Kyle Martin, Kala Levine, Gonzalo N. Olaverria Salavaggione, Tiffany Noel, Akaansha Ganju, Sarvani Uppati, Bonnie Paul, Thomas Olencki, Theodoros N. Teknos, Panos Savvides, Susheela Tridandapani, John C. Byrd, Michael A. Caligiuri, Stephen V. Liu, William E. Carson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4955–4965.
https://doi.org/10.1158/1078-0432.CCR-18-2108
Published: 15 August 2019
View article titled, A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma
Open the PDF for A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells

Elizabeth L. McMichael, Alena Cristina Jaime-Ramirez, Kristan D. Guenterberg, Eric Luedke, Lakhvir S. Atwal, Amanda R. Campbell, Zhiwei Hu, Armika S. Tatum, Sri Vidya Kondadasula, Xiaokui Mo, Susheela Tridandapani, Mark Bloomston, E. Christopher Ellison, Terence M. Williams, Tanios Bekaii-Saab, William E. Carson, III
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (2): 489–502.
https://doi.org/10.1158/1078-0432.CCR-16-0004
Published: 15 January 2017
View article titled, IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells
Open the PDF for IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis

Feng Geng, Xiang Cheng, Xiaoning Wu, Ji Young Yoo, Chunming Cheng, Jeffrey Yunhua Guo, Xiaokui Mo, Peng Ru, Brian Hurwitz, Sung-Hak Kim, Jose Otero, Vinay Puduvalli, Etienne Lefai, Jianjie Ma, Ichiro Nakano, Craig Horbinski, Balveen Kaur, Arnab Chakravarti, Deliang Guo
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5337–5348.
https://doi.org/10.1158/1078-0432.CCR-15-2973
Published: 31 October 2016
View article titled, Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis
Open the PDF for Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1–Mediated Lipogenesis in another window
Includes: Supplementary data
Journal Articles

SMARCA4/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer

Erica Hlavin Bell, Arup R. Chakraborty, Xiaokui Mo, Ziyan Liu, Konstantin Shilo, Simon Kirste, Petra Stegmaier, Maureen McNulty, Niki Karachaliou, Rafael Rosell, Gerold Bepler, David P. Carbone, Arnab Chakravarti
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (10): 2396–2404.
https://doi.org/10.1158/1078-0432.CCR-15-1468
Published: 12 May 2016
View article titled, <em>SMARCA4</em>/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer
Open the PDF for <em>SMARCA4</em>/BRG1 Is a Novel Prognostic Biomarker Predictive of Cisplatin-Based Chemotherapy Outcomes in Resected Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

Hemant K. Bid, Aaron Kibler, Doris A. Phelps, Sagymbek Manap, Linlin Xiao, Jiayuh Lin, David Capper, Duane Oswald, Brian Geier, Mariko DeWire, Paul D. Smith, Raushan T. Kurmasheva, Xiaokui Mo, Soledad Fernandez, Peter J. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (24): 6716–6729.
https://doi.org/10.1158/1078-0432.CCR-13-0842
Published: 16 December 2013
View article titled, Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an <em>In Vivo</em> Model of Childhood Astrocytoma
Open the PDF for Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an <em>In Vivo</em> Model of Childhood Astrocytoma in another window
Includes: Supplementary data
Journal Articles

DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas

Kazuo Okemoto, Kazue Kasai, Benjamin Wagner, Amy Haseley, Hans Meisen, Chelsea Bolyard, Xiaokui Mo, Allison Wehr, Amy Lehman, Soledad Fernandez, Balveen Kaur, E. Antonio Chiocca
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (21): 5952–5959.
https://doi.org/10.1158/1078-0432.CCR-12-3588
Published: 31 October 2013
View article titled, DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas
Open the PDF for DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas in another window
Includes: Supplementary data
Journal Articles

Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy

Hemant K. Bid, Cheryl A. London, Jin Gao, Haihong Zhong, Robert E. Hollingsworth, Soledad Fernandez, Xiaokui Mo, Peter J. Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 2984–2994.
https://doi.org/10.1158/1078-0432.CCR-12-2008
Published: 30 May 2013
View article titled, Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy
Open the PDF for Dual Targeting of the Type 1 Insulin-like Growth Factor Receptor and Its Ligands as an Effective Antiangiogenic Strategy in another window
Includes: Supplementary data
Journal Articles

Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74+ B-cell Malignancies

Yicheng Mao, Georgia Triantafillou, Erin Hertlein, William Towns, Matthew Stefanovski, Xiaokui Mo, David Jarjoura, Mitch Phelps, Guido Marcucci, Ly James Lee, David M. Goldenberg, Robert J. Lee, John C. Byrd, Natarajan Muthusamy
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (2): 347–356.
https://doi.org/10.1158/1078-0432.CCR-12-2046
Published: 16 January 2013
View article titled, Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74<sup>+</sup> B-cell Malignancies
Open the PDF for Milatuzumab-Conjugated Liposomes as Targeted Dexamethasone Carriers for Therapeutic Delivery in CD74<sup>+</sup> B-cell Malignancies in another window
Includes: Supplementary data
Journal Articles

Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy

Jonathan P. Butchar, Payal Mehta, Steven E. Justiniano, Kristan D. Guenterberg, Sri-Vidya Kondadasula, Xiaokui Mo, Mahesh Chemudupati, Thirumala-Devi Kanneganti, Amal Amer, Natarajan Muthusamy, David Jarjoura, Clay B. Marsh, William E. Carson, III, John C. Byrd, Susheela Tridandapani
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (7): 2065–2075.
https://doi.org/10.1158/1078-0432.CCR-09-2591
Published: 31 March 2010
View article titled, Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy
Open the PDF for Reciprocal Regulation of Activating and Inhibitory Fcγ Receptors by TLR7/8 Activation: Implications for Tumor Immunotherapy in another window